• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注射免疫刺激单链RNA引发的治疗性抗肿瘤免疫

Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.

作者信息

Scheel Birgit, Aulwurm Steffen, Probst Jochen, Stitz Lothar, Hoerr Ingmar, Rammensee Hans-Georg, Weller Michael, Pascolo Steve

机构信息

Institute for Cell Biology, Department of Immunology, University of Tübingen, Tübingen, Germany.

出版信息

Eur J Immunol. 2006 Oct;36(10):2807-16. doi: 10.1002/eji.200635910.

DOI:10.1002/eji.200635910
PMID:17013976
Abstract

Stabilized synthetic RNA oligonucleotides (ORN) and protected messenger RNA (mRNA) were recently discovered to possess an immunostimulatory capacity through their recognition by TLR 7 and 8. We wanted to find out whether this danger signal is capable of triggering anti-tumor immunity when injected locally into an established tumor. Using the mouse glioma tumor cell line SMA-560 in syngenic VM/Dk mice, we were able to show that intra-tumor injections of protamine-stabilized mRNA do indeed induce tumor regression and long-term anti-tumor immunity. Residual RNA-injected tumors show CD8 infiltration. Distant injections of protamine-protected mRNA and intra-tumor injection of naked mRNA also result in anti-tumor immunity. Although they are strong danger signals, RNA are labile molecules with a short half-life: they do not trigger side effects such as long-term, uncontrolled immunostimulation evidenced by splenomegaly in CpG DNA-treated mice. In conclusion, RNA molecules are potent and safe danger signals that are relevant for active immunotherapy strategies aimed at the eradication of solid tumors.

摘要

最近发现,稳定化的合成RNA寡核苷酸(ORN)和经保护的信使RNA(mRNA)可通过Toll样受体7(TLR 7)和Toll样受体8(TLR 8)的识别而具有免疫刺激能力。我们想弄清楚,当将这种危险信号局部注射到已形成的肿瘤中时,是否能够触发抗肿瘤免疫。利用同基因VM/Dk小鼠体内的小鼠胶质瘤肿瘤细胞系SMA-560,我们能够证明,肿瘤内注射鱼精蛋白稳定化的mRNA确实能诱导肿瘤消退和长期抗肿瘤免疫。注射RNA后残留的肿瘤出现CD8浸润。远距离注射鱼精蛋白保护的mRNA以及肿瘤内注射裸露的mRNA也会产生抗肿瘤免疫。尽管RNA是强大的危险信号,但它们是半衰期短的不稳定分子:它们不会引发诸如长期、不受控制的免疫刺激等副作用,而在经CpG DNA处理的小鼠中,脾肿大就证明了存在这种免疫刺激。总之,RNA分子是强大且安全的危险信号,与旨在根除实体瘤的主动免疫治疗策略相关。

相似文献

1
Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.注射免疫刺激单链RNA引发的治疗性抗肿瘤免疫
Eur J Immunol. 2006 Oct;36(10):2807-16. doi: 10.1002/eji.200635910.
2
Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.鱼精蛋白浓缩mRNA对几种人类血细胞类型的Toll样受体依赖性激活。
Eur J Immunol. 2005 May;35(5):1557-66. doi: 10.1002/eji.200425656.
3
Immunostimulating capacities of stabilized RNA molecules.稳定化RNA分子的免疫刺激能力。
Eur J Immunol. 2004 Feb;34(2):537-47. doi: 10.1002/eji.200324198.
4
Preventive and therapeutic antitumor effect of tumor vaccine composed of CpG ODN class C and irradiated tumor cells is triggered through the APCs and activation of CTLs.由C类CpG ODN与经照射的肿瘤细胞组成的肿瘤疫苗的预防和治疗抗肿瘤作用是通过抗原呈递细胞(APCs)和细胞毒性T淋巴细胞(CTLs)的激活来触发的。
Vaccine. 2007 Nov 28;25(49):8241-56. doi: 10.1016/j.vaccine.2007.09.067. Epub 2007 Oct 17.
5
Plasmidic CpG sequences induce tumor microenvironment modifications in a rat liver metastasis model.质粒CpG序列在大鼠肝转移模型中诱导肿瘤微环境改变。
Int J Mol Med. 2008 Mar;21(3):309-15.
6
CpG-ODN-based immunotherapy is effective in controlling the growth of metastasized tumor cells.基于CpG寡脱氧核苷酸的免疫疗法在控制转移肿瘤细胞的生长方面是有效的。
Cancer Lett. 2009 Feb 8;274(1):160-4. doi: 10.1016/j.canlet.2008.09.014. Epub 2008 Oct 25.
7
Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.在宫颈癌小鼠模型中,以靶向E6/E7的小干扰RNA进行基因沉默作为一种治疗干预手段。
Gynecol Oncol. 2008 Nov;111(2):356-64. doi: 10.1016/j.ygyno.2008.06.033. Epub 2008 Aug 27.
8
Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours.用与霍乱毒素偶联的抗原进行治疗性树突状细胞疫苗接种,并结合瘤内注射CpG,可使携带表达HPV 16肿瘤的小鼠肿瘤完全消除。
Vaccine. 2007 Aug 10;25(32):6037-46. doi: 10.1016/j.vaccine.2007.05.041. Epub 2007 Jun 8.
9
Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.直接注射信使核糖核酸的首个I/II期临床疫苗试验结果。
J Immunother. 2008 Feb-Mar;31(2):180-8. doi: 10.1097/CJI.0b013e31815ce501.
10
Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunity.用于RNA脉冲树突状细胞诱导抗肿瘤免疫的CD40连接的合适时机。
Scand J Immunol. 2008 Apr;67(4):385-91. doi: 10.1111/j.1365-3083.2008.02083.x. Epub 2008 Feb 14.

引用本文的文献

1
mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy.从实验室到临床的mRNA癌症疫苗:癌症免疫治疗的新时代。
Biomark Res. 2024 Dec 18;12(1):157. doi: 10.1186/s40364-024-00692-9.
2
Immunotherapy Vaccines for Prostate Cancer Treatment.用于前列腺癌治疗的免疫疗法疫苗。
Cancer Med. 2024 Oct;13(20):e70294. doi: 10.1002/cam4.70294.
3
Personalized mRNA vaccines in glioblastoma therapy: from rational design to clinical trials.个性化信使 RNA 疫苗在胶质母细胞瘤治疗中的应用:从合理设计到临床试验。
J Nanobiotechnology. 2024 Oct 4;22(1):601. doi: 10.1186/s12951-024-02882-x.
4
mRNA vaccines: a new era in vaccine development.mRNA 疫苗:疫苗开发的新时代。
Oncol Res. 2024 Sep 18;32(10):1543-1564. doi: 10.32604/or.2024.043987. eCollection 2024.
5
Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens.治疗性癌症疫苗与肿瘤微环境之间的双向串扰:超越肿瘤抗原
Fundam Res. 2022 Mar 26;3(6):1005-1024. doi: 10.1016/j.fmre.2022.03.009. eCollection 2023 Nov.
6
Recent Advancement in mRNA Vaccine Development and Applications.mRNA疫苗开发与应用的最新进展
Pharmaceutics. 2023 Jul 18;15(7):1972. doi: 10.3390/pharmaceutics15071972.
7
RNA with chemotherapeutic base analogues as a dual-functional anti-cancer drug.含有化疗碱基类似物的 RNA 作为一种双功能抗癌药物。
Oncoimmunology. 2022 Nov 18;11(1):2147665. doi: 10.1080/2162402X.2022.2147665. eCollection 2022.
8
Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects.基于脂质纳米颗粒的 mRNA 疫苗在癌症中的应用:当前进展和未来前景。
Front Immunol. 2022 Aug 26;13:922301. doi: 10.3389/fimmu.2022.922301. eCollection 2022.
9
mRNA vaccines in the prevention and treatment of diseases.信使核糖核酸疫苗在疾病预防和治疗中的应用
MedComm (2020). 2022 Aug 25;3(3):e167. doi: 10.1002/mco2.167. eCollection 2022 Sep.
10
The Delivery of mRNA Vaccines for Therapeutics.用于治疗的信使核糖核酸疫苗的递送
Life (Basel). 2022 Aug 17;12(8):1254. doi: 10.3390/life12081254.